Risperidone long-acting injection: A 6-year mirror-image study of healthcare resource use

Acta Psychiatrica Scandinavica

Volumn 120, Issue 2, 2009, Pages 97-101

  Taylor, D ^a,b   Fischetti, C ^a   Sparshatt, A ^a   Thomas, A ^a   Bishara, D ^a   Cornelius, V ^c  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

Antipsychotics; Bed stay; Healthcare resource; Risperidone

Indexed keywords

CLOZAPINE; LONG ACTING DRUG; RISPERIDONE;

ADULT; ARTICLE; AUTISM; BEHAVIOR DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DELUSIONAL DISORDER; DEPRESSIVE PSYCHOSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL BED UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NATURALISTIC INQUIRY; ORGANIC PSYCHOSYNDROME; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAMUSCULAR; LENGTH OF STAY; MALE; MENTAL HEALTH SERVICES; PSYCHOTIC DISORDERS; RISPERIDONE; TIME FACTORS;

EID: 67649939217     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01352.x     Document Type: Article

References (13)

1. Kane JM, Eerdekens M, Lindenmayer JP, Keith SJ, Lesem M, Karcher K. Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic. Am J Psychiatry 2003 160 : 1125 1132. (Pubitemid 41070972)
2. Keks NA, Ingham M, Khan A, Karcher K. Long-acting injectable risperidone v. olanzapine tablets for schizophrenia or schizoaffective disorder. Randomised, controlled, open-label study. Br J Psychiatry 2007 191 : 131 139. (Pubitemid 47204533)
3. Moller HJ. Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives. Drugs 2007 67 : 1541 1566.
4. Simpson GM, Mahmoud RA, Lasser RA et al. A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2006 67 : 1194 1203. (Pubitemid 44439690)
5. Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr Res 2005 77 : 215 227. (Pubitemid 41112215)
6. Llorca PM, Sacchetti E, Lloyd K, Kissling W, Medori R. Long-term remission in schizophrenia and related psychoses with long-acting risperidone: results obtained in an open-label study with an observation period of 18 months. Int J Clin Pharmacol Ther 2008 46 : 14 22.
7. Taylor M, Currie A, Lloyd K, Price M, Peperell K. Impact of risperidone long acting injection on resource utilization in psychiatric secondary care. J Psychopharmacol 2008 22 : 128 131. (Pubitemid 351322859)
8. Niaz OS, Haddad PM. Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care. Acta Psychiatr Scand 2007 116 : 36 46. (Pubitemid 46889775)
9. Young CL, Taylor DM. Health resource utilization associated with switching to risperidone long-acting injection. Acta Psychiatr Scand 2006 114 : 14 20. (Pubitemid 43885480)
10. Taylor DM, Young CL, Mace S, Patel MX. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients. J Clin Psychiatry 2004 65 : 1076 1083.
11. Taylor D, Fischetti C, Sparshatt A, Thomas A, Bishara D, Cornelius V. Risperidone long-acting injection: a prospective 3 year analysis of its use in clinical practice. J Clin Psychiatry 2008 (in press).
12. Taylor D. Risperidone long-acting injection in practice - more questions than answers? Acta Psychiatr Scand 2006 114 : 1 2. (Pubitemid 43885478)
13. Taylor DM, Young C, Patel MX. Prospective 6-month follow-up of patients prescribed risperidone long-acting injection: factors predicting favourable outcome. Int J Neuropsychopharmacol 2005 9 : 1 10.